BridgeMD
New treatment option for Drug Resistant Epilepsy
Official title A Neuro-cognitive and Psychosocial Intervention Module in People With Epilepsy
ClinicalTrials.gov ID: NCT06537986
What this study is testing
- What it's testing
- Patients with epilepsy, especially drug-resistant epilepsy, have a lot of cognitive \& psycho-social issues. There is little evidence pertaining to the efficacy of the various cognitive-behavioral interventions and cognitive retraining modules used in epilepsy patients in the Indian context.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 45
You may be able to join if
- Participants of 18 - 45 years of age.
- either gender
- Willing to participate and sign the informed consent
You likely can't join if
- Patients with other neurological disorders
- any other trial at inclusion
- should not have any major psychiatric disorder
- pregnant and lactating mothers
- also, patients who would not be giving informed consent
- Patients with intellectual disabilities.
The study team makes the final eligibility decision.
Where it's taking place
- Chandigarh, India
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 45 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Chandigarh, India. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.